41 related articles for article (PubMed ID: 17385213)
21. Fluorescence in situ hybridization to evaluate dysplasia in Barrett's esophagus: a pilot study.
Cestari R; Villanacci V; Rossi E; Della Casa D; Missale G; Conio M; Grigolato P; Bassotti G
Cancer Lett; 2007 Jun; 251(2):278-87. PubMed ID: 17321043
[TBL] [Abstract][Full Text] [Related]
22. Assessment of chromosomal gains as compared to DNA content changes is more useful to detect dysplasia in Barrett's esophagus brush cytology specimens.
Rygiel AM; Milano F; Ten Kate FJ; de Groot JG; Peppelenbosch MP; Bergman JJ; Krishnadath KK
Genes Chromosomes Cancer; 2008 May; 47(5):396-404. PubMed ID: 18265409
[TBL] [Abstract][Full Text] [Related]
23. Chromosomal gains and genomic loss of p53 and p16 genes in Barrett's esophagus detected by fluorescence in situ hybridization of cytology specimens.
Fahmy M; Skacel M; Gramlich TL; Brainard JA; Rice TW; Goldblum JR; Connor JT; Casey G; Legator MS; Tubbs RR; Falk GW
Mod Pathol; 2004 May; 17(5):588-96. PubMed ID: 15017433
[TBL] [Abstract][Full Text] [Related]
24. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
[TBL] [Abstract][Full Text] [Related]
25. Stepwise radical endoscopic resection of the complete Barrett's esophagus with early neoplasia successfully eradicates pre-existing genetic abnormalities.
Peters FP; Krishnadath KK; Rygiel AM; Curvers WL; Rosmolen WD; Fockens P; Ten Kate FJ; van Baal JW; Bergman JJ
Am J Gastroenterol; 2007 Sep; 102(9):1853-61. PubMed ID: 17509033
[TBL] [Abstract][Full Text] [Related]
26. Genetic probes in cytology: principles and applications.
Wolman SR; Sanford JS; Flom K; Feiner H; Abati A; Bedrossian C
Diagn Cytopathol; 1995 Dec; 13(5):429-35. PubMed ID: 8834317
[No Abstract] [Full Text] [Related]
27. Automated Immunostaining Platform in Cytology.
Sharma S; Dey P
J Cytol; 2021; 38(2):57-63. PubMed ID: 34321770
[TBL] [Abstract][Full Text] [Related]
28. Efficient automated assessment of genetic abnormalities detected by fluorescence in situ hybridization on brush cytology in a Barrett esophagus surveillance population.
Rygiel AM; van Baal JW; Milano F; Wang KK; ten Kate FJ; Fockens P; Rosmolen WD; Bergman JJ; Peppelenbosch MP; Krishnadath KK
Cancer; 2007 May; 109(10):1980-8. PubMed ID: 17385213
[TBL] [Abstract][Full Text] [Related]
29. Advanced microtechnologies for detection of chromosome abnormalities by fluorescent in situ hybridization.
Kwasny D; Vedarethinam I; Shah P; Dimaki M; Silahtaroglu A; Tumer Z; Svendsen WE
Biomed Microdevices; 2012 Jun; 14(3):453-60. PubMed ID: 22222279
[TBL] [Abstract][Full Text] [Related]
30. State-of-the-art FISHing: automated analysis of cytogenetic aberrations in interphase nuclei.
Pajor G; Kajtár B; Pajor L; Alpár D
Cytometry A; 2012 Aug; 81(8):649-63. PubMed ID: 22696411
[TBL] [Abstract][Full Text] [Related]
31. Application of Fluorescence In Situ Hybridization (FISH) Technique for the Detection of Genetic Aberration in Medical Science.
Ratan ZA; Zaman SB; Mehta V; Haidere MF; Runa NJ; Akter N
Cureus; 2017 Jun; 9(6):e1325. PubMed ID: 28690958
[TBL] [Abstract][Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
